Intervention
Folinic acid
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownCommon conditions
Adenocarcinoma of the Pancreas1Adjuvant Arthritis1Advanced Cancer1Carcinoma1Endometrial Adenocarcinoma1Gastric Adenocarcinoma1Gastric Cancer1Gastroesophageal Junction Adenocarcinoma1Neoplasms1Pancreatic Adenocarcinoma1Pancreatic Ductal Adenocarcinoma1Rheumatoid Arthritis1Small Cell Lung Carcinoma1Small-cell Lung Cancer1Solid Carcinoma1Solid Tumor1Squamous Cell Carcinoma1Squamous Cell Carcinoma of the Anus1Squamous Cell Carcinoma of the Cervix1Squamous Cell Carcinoma of the Penis1Squamous Cell Carcinoma of the Vulva1
Leading sponsors
Trial status mix
COMPLETED1
UNKNOWN1
Phase mix
PHASE22
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.